Table 1 Characteristics of the patients and normal controls.

Demographic

Age, years (range)

61 (18–98)

49 (10–78)^†

30 (21–58)^†

Male sex, (%)

127 (63)

148 (69)

12 (40)^†

BSA, m²

1.76 ± 0.18

1.75 ± 0.22

1.68 ± .68

Hct, (%)

42.5 ± 4.7

42.2 ± 4.5

42.9 ± 2.8

Time interval between the date of Hct and CMR, days (IQR)

130 (1–72)

93 (1–39)

0

Amyloidosis, (%)

15 (7)

ARVC, (%)

47 (22)

BrS (%)

64 (30)

DCM, (%)

37 (17)

Fabry, (%)

24 (11)

HTC, (%)

81 (40)

HCM, (%)

87 (43)

HFpEF, (%)

28 (14)

ICM, (%)

21 (10)

Myocarditis, (%)

14 (7)

LV function by CMR

LVEDV_i, ml/m²

54.4 ± 12.9

70.6 ± 32.5^†

64.3 ± 12.3^†

LVESV_i, ml/m²

11.7 ± 8.97

25.9 ± 28.8^†

18.7 ± 6.3^†

EF, %

79.9 ± 9.9

69.4 ± 15.8^†

72.2 ± 5.1^†

PER, s⁻¹

− 4.6 ± 1.19

− 3.48 ± 1.19^†

− 3.49 ± 0.79^†

PFR, s⁻¹

4.02 ± 1.59

3.89 ± 1.66

5.52 ± 1.30*^†

LVM_i, g/m²

152 ± 66

121 ± 59^†

88 ± 26*^†